FDA Inspection 718224 — Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals Inc. — FEI 3004097115

The FDA completed an inspection of Lupin Pharmaceuticals Inc. on Apr 6, 2011 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 6, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Naples, FL (United States)